We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Clinical Laboratory Diagnostics Tool Targeted Towards Addiction

By LabMedica International staff writers
Posted on 30 Jun 2010
A privately held clinical urine drug-testing laboratory offers a reporting service that provides clinicians with accurate testing results and analytical feedback to augment the assessment and monitoring of an individual's drug use upon admission and throughout the course of addiction treatment.

The new Comprehensive Analysis of Reported Drugs (CARD) reporting service was developed to create a highly personalized clinical report by correlating an individual's prescribed medication use and self-reported drug misuse with its state-of-the-art diagnostic testing.

Dominion Diagnostics (North Kingstown, RI, USA) performs all the necessary testing at its laboratory and turns around testing results to clients through a number of different formats. More...
The initial results are deliverable 24 hours from receipt of the specimen in the laboratory, with confirmatory results by alternate method available within a few days. Dominion works with a variety of medical specialties, but the new CARD report is in fact targeted towards addiction treatment and behavioral health.

CARD utilizes laboratory results from validated quantitative urine drug testing profiles for commonly abused illicit and prescription drugs and/or their metabolites, as well as biological markers and commercial adulterant screening (i.e., creatinine, specific gravity, pH, and oxidants) to ensure specimen validity.

The results provide data to support and measure a treatment program's ability to reduce morbidity in substance abuse, improve retention in treatment, and promote the use of evidence-based practice for individuals suffering from addiction and mental health disorders, in line with ongoing initiatives supported by the Substance Abuse and Mental Health Services Agency (SAMHSA; Rockville, MD, USA).

Dominion Diagnostics is a premier provider of comprehensive clinical quantitative urine drug testing, medication monitoring, and support services nationwide.

Related Links:
Dominion Diagnostics
Substance Abuse and Mental Health Services Agency



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.